March 14, 2024
The US Food and Drug Administration (FDA) has approved tislelizumab-jsgr (Tevimbra, BeiGene, Ltd.) as second-line monotherapy for certain adult patients with unresectable or metastatic esophageal squamous […]
March 14, 2024
The US Food and Drug Administration (FDA) has approved resmetirom (Rezdiffra, Madrigal Pharmaceuticals), the first drug to treat patients with metabolic dysfunction–associated steatohepatitis (MASH) and moderate […]
March 14, 2024
For Immediate Release: March 14, 2024 Today, the U.S. Food and Drug Administration approved Rezdiffra (resmetirom) for the treatment of adults with noncirrhotic non-alcoholic steatohepatitis (NASH) […]
March 14, 2024
Share on PinterestWomen with depression are at higher risk for heart disease compared to men with depression, a new study found. Xavier Lorenzo/Getty Images Females with […]
March 14, 2024
Share on PinterestHealthgrades has announced the 2024 recipients of the Patient Safety Excellence and Outstanding Patient Experience Awards. Tom Werner/Getty Images Healthgrades has announced the winners […]
March 14, 2024
Share on PinterestA rare but serious infection can occur with nasal irrigation devices. South Agency/Getty Images New research from the Centers for Disease Control (CDC) has […]
March 14, 2024
HOW TO USE THIS SNAPSHOTThe information provided in Snapshots highlights who participated in the key clinical trials that supported the original FDA approval of this drug, […]
March 14, 2024
FDA has released several FRNs over the past few years covering the PQ/CMC project. As new sections of Module 3 eCTD (Electronic Common Technical Document) are […]
March 14, 2024
About 7% of US adults report having or having had symptoms of long COVID such as fatigue, heart palpitations and/or dizziness. These are three of the […]